Quick Answer
Corbus Pharmaceuticals Holdings, Inc. reported Total Revenue of $0.00 for fiscal year 2022.
Corbus Pharmaceuticals Holdings, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2022 | $0.00 | -100.0% |
| 2021 | $881.7K | -77.6% |
| 2020 | $3.94M | -89.1% |
| 2019 | $36.14M | +649.5% |
| 2018 | $4.82M | +97.6% |
| 2017 | $2.44M | +27.7% |
| 2016 | $1.91M | +194.8% |
| 2015 | $648.4K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $0.00 | -100.0% | — |
| March 31, 2022 | $0.00 | -100.0% | -100.0% |
| September 30, 2021 | $97.3K | -92.1% | -28.7% |
| June 30, 2021 | $136.6K | -52.3% | -78.9% |
| March 31, 2021 | $647.8K | -63.2% | -47.4% |
| September 30, 2020 | $1.23M | -52.5% | +329.8% |
| June 30, 2020 | $286.3K | -99.0% | -83.7% |
| March 31, 2020 | $1.76M | -6.6% | -32.0% |
- Corbus Pharmaceuticals Holdings, Inc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Over the 2015–2022 period, Corbus Pharmaceuticals Holdings, Inc.’s total revenue has declined by 100.0% (from $648.4 thousand to $0.00).
- The most recent figure is from Corbus Pharmaceuticals Holdings, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 7, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: